NVST — what changed in the latest 10-Q
A section-by-section comparison of NVST's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-05 vs the prior 10-Q · 2026-05-06
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +31 | −24 | ~15 | 30 |
| Market risk (Item 3) | Text added/removed | +1 | −1 | ~1 | 1 |
| Controls & procedures | Text added/removed | 0 | 0 | ~1 | 1 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Risk factors | Text added/removed | +1 | −3 | 0 | 0 |
| Other information | Text added/removed | +1 | −5 | 0 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-05
Increasing protectionism and economic nationalism may lead to further changes in trade policies and regulations, domestic sourcing initiatives, or other formal and informal measures that could make it more difficult to sell our products in, or restrict our access to, certain markets. During 2025 and…
While the IEEPA tariffs were invalidated by the Supreme Court, the U.S. Administration initiated new tariffs on all imports, subject to certain exceptions, and may impose additional tariffs. As a result, it remains difficult to predict what further trade-related actions governments may take, which m…
On a period-over-period basis, currency exchange rates positively impacted reported sales by 1.6% and 2.8% for the three and six months ended July 3, 2026 compared to the comparable periods of 2025, primarily due to the weakening U.S. dollar against most major currencies. Any future weakening of the…
% Change Six Month Period Ended July 3, 2026 vs. Comparable 2025 Period
Sales for the three months ended July 3, 2026 increased 7.1% while core sales growth increased by 5.0% as compared to the comparable period in 2025. An increase in sales volume of 3.2% positively impacted sales on a period-over-period basis, coupled with an increase in sales price of 1.8%. Geographi…
Text removed vs the prior filing · source: 10-Q · 2026-05-06
Increasing protectionism and economic nationalism may lead to further changes in trade policies and regulations, domestic sourcing initiatives, or other formal and informal measures that could make it more difficult to sell our products in, or restrict our access to, certain markets. During 2025 and…
On a period-over-period basis, currency exchange rates positively impacted reported sales by 4.3% for the three months ended April 3, 2026 compared to the comparable period of 2025, primarily due to the weakening U.S. dollar against most major currencies. Any future weakening of the U.S. dollar agai…
Our aligner business, included in our Specialty Products & Technologies segment, enters into revenue contracts that involve multiple performance obligations which include optional aligners at no additional charge. Our treatment plans are comprised of the following performance obligations: initial al…
We continually review and update the usage rate and other related assumptions. Future changes to usage rates and related assumptions may impact the pattern of revenue recognition for future treatment plans. The process of estimating the number of times a clear aligner customer is expected to order a…
Sales for the three months ended April 3, 2026 increased 14.4% while core sales growth increased by 9.5% as compared to the comparable period in 2025. An increase in sales volume of 7.8% positively impacted sales on a period-over-period basis, coupled with an increase in sales price of 1.7%.
Market risk (Item 3)
Text added vs the prior filing · source: 10-Q · 2026-08-05
For additional information on hedging transactions and derivative financial instruments, please refer to Note 9 to our Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q. Other than as set forth herein, there have been no material changes in our primary market risk exp…
Text removed vs the prior filing · source: 10-Q · 2026-05-06
For additional information on hedging transactions and derivative financial instruments, please refer to Note 9 to our Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q.
Risk factors
Text added vs the prior filing · source: 10-Q · 2026-08-05
You should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our 2025 10-K and in Part II, “Item 1A. Risk Factors” in our Quarterly Report on Form 10-Q for the quarter ended April 3, 2026 (“Q1 10-Q”), which could materially affect our business, financial position, or fut…
Text removed vs the prior filing · source: 10-Q · 2026-05-06
You should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our 2025 10-K. The risks described in our 2025 10-K are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially ad…
The conflict between the United States, Israel and Iran and related geopolitical instability may adversely affect our business.
In February 2026, the United States and Israel launched coordinated military strikes against Iran, which retaliated with missile attacks across the region. The ongoing conflict and any further escalation, including additional military actions, retaliatory measures, sanctions, disruptions to trade or…
Other information
Text added vs the prior filing · source: 10-Q · 2026-08-05
(c) Our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) may from time to time enter into plans for the purchase or sale of our common stock that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. During the quarter ended J…
Text removed vs the prior filing · source: 10-Q · 2026-05-06
(a) On May 5, 2026, our Board of Directors authorized a new stock repurchase program, pursuant to which we may purchase up to $300.0 million of our outstanding common stock through December 31, 2029. Under the stock repurchase program, we may repurchase our common stock from time to time, in amounts…
For information about our current Repurchase Program, please refer to Part II, Item 2 “Unregistered Sales of Equity Securities and Use of Proceeds” in this Quarterly Report on Form 10-Q.
(c) Our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) may from time to time enter into plans for the purchase or sale of our common stock that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. During the quarter ended A…
Our Senior Vice President, Strategy and Corporate Development, Mischa Reis, adopted a 10b5-1 trading plan on February 27, 2026. The adoption of such 10b5-1 trading plan occurred during an open trading window and complied with the Company’s policies on insider trading. The first trade will not occur …
Other than as described above, during the quarter ended April 3, 2026, none of our directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of …
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice